Search Results - "Schmutz, Jean‐Luc"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Prevalence of ocular disease during dupilumab treatment for atopic dermatitis: a bicentric retrospective comparative cohort study by Barbé, Jordane, Poreaux, Claire, Remen, Thomas, Schoeffler, Amélie, Cloché, Véronique, Schmutz, JeanLuc, Escobar, Gabriela, Busztejn, Anne‐Claire

    Published in International journal of dermatology (01-12-2021)
    “…Background Dupilumab is the first human monoclonal antibody approved for the treatment of atopic dermatitis (AD). Clinical trials have reported an increase of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions by Lerondeau, Bérangère, MD, Trechot, Philippe, PharmD, Waton, Julie, MD, Poreaux, Claire, MD, Luc, Amandine, MD, Schmutz, Jean-Luc, MD, Paris, Christophe, MD, PhD, Barbaud, Annick, MD, PhD

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…To the Editor: Radiocontrast media (RCM) are responsible for immediate (likely to be IgE- or complement-mediated) or delayed adverse reactions thought to be…”
    Get full text
    Journal Article
  7. 7

    Methylisothiazolinone allergic contact dermatitis: Assessment of relapses in 139 patients after avoidance advice by Bouschon, Pauline, Waton, Julie, Pereira, Bruno, Schmutz, JeanLuc, Bouëdec, Marie‐Christine F., D'Incan, Michel

    Published in Contact dermatitis (01-05-2019)
    “…Background Methylisothiazolinone (MI) is a preservative that is responsible for an epidemic of allergic contact dermatitis (ACD). Few studies have been…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    A new sunscreen application technique to protect more efficiently from ultraviolet radiation by Jeanmougin, Michel, Bouloc, Anne, Schmutz, Jean-Luc

    “…Summary Background UV radiation protection is an important health issue. Sophisticated sunscreen formulations have been developed to improve compliance…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstration by Trechot, Philippe, Jouzeau, Jean-Yves, Brouillard, Clotilde, Scala-Bertola, Julien, Petitpain, Nadine, Cuny, Jean-François, Gauchotte, Guillaume, Schmutz, Jean-Luc, Barbaud, Annick

    Published in International wound journal (01-10-2015)
    “…Nicorandil, a nicotinamide ester, was first reported to be involved in the induction of oral ulcers in 1997. Since then, many reports of single or multiple…”
    Get full text
    Journal Article
  18. 18

    Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial by Schmutz, Jean-Luc, Meaume, Sylvie, Fays, Ségolène, Ourabah, Zohva, Guillot, Bernard, Thirion, Valéne, Collier, Mark, Barrett, Simon, Smith, J, Bohbot, Serge, Dompmartin, Anne

    Published in International wound journal (01-05-2008)
    “…The nano‐oligosaccharide factor (NOSF) is a new compound aiming to promote wound closure mainly through inhibition of matrix metalloproteinase (MMP) activity…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A case of cutaneous lichen sclerosus et atrophicus effectively treated by extracorporeal photochemotherapy by Brouillard, Clotilde, Granel-Brocard, Florence, Cuny, Jean-François, Truchetet, François, Schmutz, Jean-Luc

    “…Summary Lichen sclerosus et atrophicus (LSA) is an inflammatory disease that affects the genitals, which was first described by Hallopeau in 1887 and is of…”
    Get full text
    Journal Article